Zealand Pharma
Zealand Pharma is a biotechnology company based in Copenhagen, Denmark. The company specializes in the discovery, design, and development of innovative peptide-based medicines. Zealand Pharma's portfolio includes medicines for diseases such as diabetes, obesity, cardiovascular diseases, and gastrointestinal diseases.
History[edit]
Zealand Pharma was founded in 1998 with the aim of developing novel peptide-based medicines. The company has since grown to become a leader in its field, with several products on the market and a strong pipeline of investigational drugs.
Research and Development[edit]
Zealand Pharma's research and development efforts are focused on the therapeutic areas of metabolic diseases, cardiovascular diseases, and gastrointestinal diseases. The company uses its proprietary platform to design and develop peptide-based medicines.
Products[edit]
Zealand Pharma's product portfolio includes Lixisenatide (marketed as Lyxumia®), a once-daily prandial GLP-1 receptor agonist for the treatment of type 2 diabetes, and Suliqua™, a combination of Lixisenatide and insulin glargine for the treatment of type 2 diabetes.
Pipeline[edit]
Zealand Pharma has a robust pipeline of investigational drugs in various stages of development. These include potential treatments for short bowel syndrome, congenital hyperinsulinism, and obesity.
Partnerships[edit]
Zealand Pharma has established partnerships with several major pharmaceutical companies, including Sanofi, Boehringer Ingelheim, and AbbVie.
See Also[edit]
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
